Skip to main content

Table 2 Univariate analysis

From: Prediction of functional outcome in patients with convulsive status epilepticus: the END-IT score

Variable

Total (n = 132)

mRS:0–2 (n = 70)

mRS:3–6 (n = 62)

P

Age, median (IQR), y

25.5 (17.0, 48.0)

24 (17.0, 34.5)

31 (18.8, 54.3)

0.075 (Mann–Whitney U)

Gender, male, No. (%)

80 (60.6)

40 (57.1)

40 (64.5)

0.387 (χ 2)

History of epilepsy, No. (%)

54 (40.9)

28 (40.0)

26 (41.9)

0.821 (χ 2)

GCS on admission 3–8, No. (%)

54 (40.9)

22 (31.4)

32 (51.6)

0.019 (χ 2)

Pupillary light reflex on admission, slow or absence, No. (%)

36 (27.3)

15 (21.4)

21 (33.9)

0.109 (χ 2)

Encephalitis, No. (%)

47 (35.6)

15 (21.4)

32 (51.6)

<0.001 (χ 2)

Complicated with NCSE, No. (%)

63 (47.7)

23 (32.9)

40 (64.5)

<0.001 (χ 2)

Diazepam resistance, No. (%)

82 (62.1)

32 (45.7)

50 (80.6)

<0.001 (χ 2)

Image

   

0.007 (χ 2)

 unilateral lesions, No. (%)

28 (21.2)

16 (22.9)

12 (19.4)

 

 bilateral lesions/diffuse cerebral edema, No. (%)

63 (47.7)

25 (35.7)

38 (61.3)

 

Tracheal intubation, No. (%)

41 (31.1)

11 (15.7)

30 (48.4)

<0.001 (χ 2)

Duration >2 h, No. (%)

81 (61.4)

34 (48.6)

47 (75.8)

0.001 (χ 2)

Drug induced coma, No. (%)

42 (31.8)

15 (21.4)

27 (43.5)

0.006 (χ 2)

Usage of ≥3 types vAEDs, No. (%)

73 (55.3)

32 (45.7)

41 (66.1)

0.019 (χ 2)

CCI

   

0.260 (χ 2)

 1–2

36 (27.3)

17 (24.3)

19 (30.6)

 

 3 or more

18 (13.6)

5 (7.1)

13 (21.0)

 
  1. mRS modified Rankin Scale, IQR interquartile range, GCS Glasgow coma scale, NCSE nonconvulsive status epilepticus, SE status epilepticus, vAEDs intravenous antiepileptic drugs, CCI Charlson’s Comorbidity Index